NM_152594.3:c.676C>T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_152594.3(SPRED1):c.676C>T(p.Gln226*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_152594.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 27
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Legius syndrome Pathogenic:1
This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. A different truncation (p.Met266Valfs*4) that lies downstream of this variant has been determined to be pathogenic (PMID: 17704776, 22751498). This suggests that deletion of this region of the SPRED1 protein is causative of disease. This variant has not been reported in the literature in individuals with SPRED1-related disease. ClinVar contains an entry for this variant (Variation ID: 536686). This sequence change results in a premature translational stop signal in the SPRED1 gene (p.Gln226*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 219 amino acids of the SPRED1 protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at